Full-Time

Life Sciences Counsel

Confirmed live in the last 24 hours

Penumbra Inc

Penumbra Inc

1,001-5,000 employees

Develops medical devices for vascular conditions

Compensation Overview

$160k - $220kAnnually

+ Competitive Compensation Package + Equity Program

Senior, Expert

Company Historically Provides H1B Sponsorship

Alameda, CA, USA

The position is onsite in Alameda, CA.

Category
Legal
Risk & Compliance
Legal & Compliance
Required Skills
Word/Pages/Docs
Excel/Numbers/Sheets
Requirements
  • Juris Doctorate and membership with the California Bar, or at least one other state’s bar, and the ability to obtain registered in-house counsel status with 6+ years of experience, or equivalent combination of education and experience
  • 6+ years of relevant legal experience, with at least 4+ years of experience advising on clinical contracting and/or regulatory matters in-house
  • Medical device, pharmaceutical, biotech, or other regulated industry experience strongly desired
  • Sound judgment; demonstrated analytical, oral, and written communication abilities; and excellent interpersonal skills
  • Experience in advising clients and/or internal business departments on relevant regulatory and healthcare compliance-related issues, including Anti-Kickback Statute, False Claims Act and current FDA and OIG guidance
  • High degree of accuracy and attention to detail
  • Proficiency with MS Word, Excel, and PowerPoint
  • Proven ability to prioritize assignments while handling various initiatives and projects simultaneously
Responsibilities
  • Provide strategic advice, legal direction, and training on applicable laws and regulations related to the advertising and promotion of medical devices; offer regular updates to key stakeholders as relevant regulatory authorities update guidance and as enforcement activities develop
  • Support all legal aspects of clinical trial programs, including assessment of related risks and creation of efficiencies across clinical trial programs
  • Provide pragmatic, business-oriented advice to Company management and key department stakeholders, including close coordination with Sales and Marketing, Regulatory, Clinical Research and Finance
  • Review and negotiate a variety of contracts, including vendor agreements, regulatory service agreements and clinical trial agreements
  • Partner with Legal Operations and Privacy teams to ensure all relevant issues are addressed consistently and to continue fostering efficiencies across the department
  • Work closely with a collaborative team of paralegals, contract specialists and administrators professionals in the day-to-day contract drafting and negotiation process, adding to a positive and productive working team dynamic
  • Help to shape and continuously improve contract templates and playbooks
  • Adhere to the Company’s Quality Management System (QMS) as well as domestic and global quality system regulations, standards, and procedures
  • Understand relevant security, privacy and compliance principles and adhere to the regulations, standards, and procedures that are applicable to the Company
  • Ensure other members of the department follow the QMS, regulations, standards, and procedures
  • Perform other work-related duties as assigned
Desired Qualifications
  • Medical device, pharmaceutical, biotech, or other regulated industry experience strongly desired

Penumbra Inc. specializes in creating medical devices aimed at treating neurovascular and peripheral vascular conditions. Their products, such as the Penumbra System and the Indigo System, are designed to assist healthcare professionals in addressing issues like stroke and other vascular diseases. These devices work by providing advanced tools for interventions in neurology and vascular surgery, allowing for effective treatment options. Unlike many competitors, Penumbra focuses specifically on these specialized areas, ensuring their products are tailored to the needs of medical professionals in hospitals and clinics across Europe and the Americas. The company's goal is to continuously innovate and improve their medical devices, enhancing the quality of care provided to patients.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Alameda, California

Founded

2004

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing demand for minimally invasive procedures boosts Penumbra's market potential.
  • Global neurovascular devices market is projected to grow at 8.5% CAGR until 2030.
  • Technological advancements enhance effectiveness of Penumbra's neurovascular treatments.

What critics are saying

  • Leadership gap due to Don Kassing's retirement may affect strategic decisions.
  • Costa Rica manufacturing expansion could face operational challenges and increased costs.
  • Layoffs in Immersive Healthcare division indicate potential strategic instability.

What makes Penumbra Inc unique

  • Penumbra specializes in neurovascular and peripheral vascular medical devices.
  • The company offers innovative solutions for stroke and neurovascular disease treatment.
  • Penumbra's global presence spans North America, Europe, Asia, and Australia.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Parental Leave

Paid Vacation

Paid Sick Leave

Paid Holidays

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Neuro News International
Feb 28th, 2025
Penumbra launches Access25 delivery microcatheter designed for brain aneurysm access

Penumbra launches Access25 delivery microcatheter designed for brain aneurysm access.

Penumbrainc
Feb 27th, 2025
Penumbra Launches ACCESS25[TM] Delivery Microcatheter Designed for Aneurysm Access and Delivery of Elevated Clinical Benefits

Penumbra recently launched the ACCESS25 Delivery Microcatheter, a single lumen medical device designed to aid physicians in accessing the neurovasculature for the delivery of Penumbra's advanced .020" coil platform.

PR Newswire
Feb 21st, 2025
Penumbra, Inc. Announces Don Kassing Will Retire From Board Of Directors

ALAMEDA, Calif., Feb. 21, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, announced today that after 17 years of distinguished service, Don Kassing has notified the company that he will retire from the board of directors effective April 1, 2025. Kassing joined Penumbra's Board of Directors in 2008 and has served as Presiding Director since 2015."We are grateful for Don's many contributions to the board over the years, particularly his wisdom and guidance in complex situations and through our phases of growth," said Adam Elsesser, board chair, president and chief executive officer of Penumbra. "We also thank Don for his steadfast leadership and dedication to helping Penumbra advance our mission of helping more and more people over the years."Mr. Kassing is President Emeritus of San Jose State University

Investing.com
Feb 19th, 2025
UBS raises Penumbra stock price target to $320, keeps buy rating

Penumbra plans to expand its manufacturing capacity with a new facility in Costa Rica.

PR Newswire
Feb 18th, 2025
Penumbra, Inc. Reports Fourth Quarter And Full Year 2024 Financial Results

ALAMEDA, Calif., Feb. 18, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the fourth quarter and full year ended December 31, 2024. Financial Highlights: Adjusted revenue1 of $321.3 million, excluding the $5.8 million impact of the Italian government's payback provision pertaining to prior years, an increase of 12.9% adjusted2 or 13.0% in adjusted constant currency2 compared to the fourth quarter of 2023. Adjusted revenue1 of $1,200.4 million, excluding the $5.8 million impact of the Italian government's payback provision pertaining to prior years, an increase of 13.4% in adjusted2 and adjusted constant currency2 compared to the full year 2023